Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-26 @ 8:13 AM
Study NCT ID:
NCT01529359
Status:
COMPLETED
Last Update Posted:
2021-04-20
First Post:
2011-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irritable Bowel Syndrome and Lactibiane Tolerance
Sponsor:
PiLeJe
Organization:
Study Overview
Official Title:
Effect of Lactibiane Tolerance on Symptoms Severity of Irritable Bowel Syndrome
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS).
Detailed Description:
The primary purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS).
The secondary purposes are to evaluate the effects of the intervention on:
* quality of life
* severity of fatigue, anxiety and depression
* levels of inflammatory markers in blood and tools
The secondary purposes are to evaluate the effects of the intervention on:
* quality of life
* severity of fatigue, anxiety and depression
* levels of inflammatory markers in blood and tools
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: